Invests in
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Education
- Uo
- PU
Lists including Mo
Work Experience
2024
Equity Analyst
2024
Healthcare investment
2023 - 2023
Equity Analyst Intern
2023 - 2023
2019 - 2022
Associate
2020 - 2022
6 Dimensions Capital is a leading healthcare-focused, cross-border VC in China with $2.3 billion AUM. Portofolio include Grail, Viela Bio, OcuMension, Brii Biosciences, CStone and many others. -My responsibilities at 6DC include venture formation, early stage deal sourcing and due dilligence, as well as portofolio support in the biotech and pharma sector. -Core deal team member of Cutia Therapeutics (HKEX ticker: 2487.HK), Ignis Therapeutics ($180m series A, one of the largest in China pharma sector) and a stealth mode biotech focused on next-gen protein therapeutics ($20m pre-A raise) https://www.cutiatx.com/ https://www.dealstreetasia.com/stories/ignis-funding-269621
Analyst
2019 - 2020
Analyst Intern
2019 - 2019
2018 - 2019
Analyst Intern
2018 - 2019
Healthcare investment team intern
2017 - 2018
Vice President Of Business Development
2017 - 2018
-With a team delivered five conferences with over 100 attendees. -With a team delivered the annual ImagineIF start-up competition, attracted over 20 local applicants. -Worked in the core team and delivered a global biomedical innovation conference, with over 500 delegates.